283 related articles for article (PubMed ID: 18284399)
41. Itching in patients suffering from psoriasis.
Szepietowski JC; Reich A; Wiśnicka B
Acta Dermatovenerol Croat; 2002 Dec; 10(4):221-6. PubMed ID: 12588672
[TBL] [Abstract][Full Text] [Related]
42. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
[TBL] [Abstract][Full Text] [Related]
43. Nail changes in childhood psoriasis: a study from Kuwait.
Al-Mutairi N; Manchanda Y; Nour-Eldin O
Pediatr Dermatol; 2007; 24(1):7-10. PubMed ID: 17300641
[TBL] [Abstract][Full Text] [Related]
44. Nail psoriasis in Germany: epidemiology and burden of disease.
Augustin M; Reich K; Blome C; Schäfer I; Laass A; Radtke MA
Br J Dermatol; 2010 Sep; 163(3):580-5. PubMed ID: 20456340
[TBL] [Abstract][Full Text] [Related]
45. Nailing down the genetic and immunological basis for psoriatic disease.
McGonagle D; Palmou Fontana N; Tan AL; Benjamin M
Dermatology; 2010; 221 Suppl 1():15-22. PubMed ID: 20733311
[TBL] [Abstract][Full Text] [Related]
46. Enthesitis: an autoinflammatory lesion linking nail and joint involvement in psoriatic disease.
McGonagle D
J Eur Acad Dermatol Venereol; 2009 Sep; 23 Suppl 1():9-13. PubMed ID: 19686380
[TBL] [Abstract][Full Text] [Related]
47. Neuropeptides and their receptors in psoriatic skin in relation to pruritus.
Chang SE; Han SS; Jung HJ; Choi JH
Br J Dermatol; 2007 Jun; 156(6):1272-7. PubMed ID: 17535226
[TBL] [Abstract][Full Text] [Related]
48. Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study.
Brunasso AM; Puntoni M; Aberer W; Delfino C; Fancelli L; Massone C
Br J Dermatol; 2013 Jun; 168(6):1243-51. PubMed ID: 23301847
[TBL] [Abstract][Full Text] [Related]
49. A study examining inter-rater and intrarater reliability of a novel instrument for assessment of psoriasis: the Copenhagen Psoriasis Severity Index.
Berth-Jones J; Thompson J; Papp K;
Br J Dermatol; 2008 Aug; 159(2):407-12. PubMed ID: 18565187
[TBL] [Abstract][Full Text] [Related]
50. Acceptance of chronic illness in psoriasis vulgaris patients.
Zalewska A; Miniszewska J; Chodkiewicz J; Narbutt J
J Eur Acad Dermatol Venereol; 2007 Feb; 21(2):235-42. PubMed ID: 17243960
[TBL] [Abstract][Full Text] [Related]
51. The impact of changes in clinical severity on psychiatric morbidity in patients with psoriasis: a follow-up study.
Sampogna F; Tabolli S; Abeni D;
Br J Dermatol; 2007 Sep; 157(3):508-13. PubMed ID: 17627789
[TBL] [Abstract][Full Text] [Related]
52. [Clinical experience with etanercept in the treatment of psoriasis].
Martín B; Sánchez-Carazo JL; Pérez-Ferriols A; Laguna C; Oliver V; Alegre V
Actas Dermosifiliogr; 2008 Sep; 99(7):540-5. PubMed ID: 18682167
[TBL] [Abstract][Full Text] [Related]
53. Nail psoriasis: a review.
Tan ES; Chong WS; Tey HL
Am J Clin Dermatol; 2012 Dec; 13(6):375-88. PubMed ID: 22784035
[TBL] [Abstract][Full Text] [Related]
54. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis.
Chandran V; Gottlieb A; Cook RJ; Duffin KC; Garg A; Helliwell P; Kavanaugh A; Krueger GG; Langley RG; Lynde C; McHugh N; Mease P; Olivieri I; Rahman P; Rosen CF; Salvarani C; Thaci D; Toloza SM; Wong MY; Zhou QM; Gladman DD
Arthritis Rheum; 2009 Sep; 61(9):1235-42. PubMed ID: 19714610
[TBL] [Abstract][Full Text] [Related]
55. Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment.
Sánchez Regaña M; Márquez Balbás G; Umbert Millet P
J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):963-9. PubMed ID: 18410337
[TBL] [Abstract][Full Text] [Related]
56. Vascular endothelial growth factor in psoriasis: an indicator of disease severity and control.
Nofal A; Al-Makhzangy I; Attwa E; Nassar A; Abdalmoati A
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):803-6. PubMed ID: 19309427
[TBL] [Abstract][Full Text] [Related]
57. Clinical study of psoriasis occurring over the age of 60 years: is elderly-onset psoriasis a distinct subtype?
Kwon HH; Kwon IH; Youn JI
Int J Dermatol; 2012 Jan; 51(1):53-8. PubMed ID: 22182378
[TBL] [Abstract][Full Text] [Related]
58. The expression of serotonin transporter protein correlates with the severity of psoriasis and chronic stress.
Thorslund K; Amatya B; Dufva AE; Nordlind K
Arch Dermatol Res; 2013 Mar; 305(2):99-104. PubMed ID: 23161175
[TBL] [Abstract][Full Text] [Related]
59. Observations of psoriasis in the absence of therapeutic intervention identifies two unappreciated morphologic variants, thin-plaque and thick-plaque psoriasis, and their associated phenotypes.
Christensen TE; Callis KP; Papenfuss J; Hoffman MS; Hansen CB; Wong B; Panko JM; Krueger GG
J Invest Dermatol; 2006 Nov; 126(11):2397-403. PubMed ID: 16858419
[TBL] [Abstract][Full Text] [Related]
60. Economic evaluation of etanercept in the management of chronic plaque psoriasis.
Lloyd A; Reeves P; Conway P; Reynolds A; Baxter G
Br J Dermatol; 2009 Feb; 160(2):380-6. PubMed ID: 18808413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
